Clinical trial
Collagen-targeted PET Imaging for Assessment of EGCG Effect
NCT06265532 is registered in ClinicalTrials.gov with Hal Chapman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Collagen-targeted PET Imaging for Assessment of EGCG Effect
- Lead sponsor
- Hal Chapman
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 7, 2024
- Completion date
- January 8, 2026
- Enrollment
- 12 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.